Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa (mesalamine) is a small molecule pharmaceutical. Mesalamine was first approved as Apriso on 1987-12-24. It is used to treat proctitis, sigmoid diseases, and ulcerative colitis in the USA. It is known to target peroxisome proliferator-activated receptor gamma. Pentasa's patents are valid until 2030-05-01 (FDA).
|Trade Name||Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa|
|Indication||proctitis, sigmoid diseases, ulcerative colitis|
|Drug Class||Anti-inflammatory agents (salicylic acid derivatives)|